Evidence map›Paper›PMID 35699227›Full record

ArticleClinical genetics2022

Carriers of COL3A1 pathogenic variants in Denmark: Interfamilial variability in severity and outcome of elective surgical procedures.

Sofus Sølyst, Riina Oksjoki, Stense Farholt, Dorte Guldbrand Nielsen, Alex H Christensen, Christina R Fagerberg, Lotte Risom, Pernille Axél Gregersen, Maria Bejerholm Christensen, Torsten Bloch Rasmussen and 1 more

Abstract read
In one paragraph

Article in Clinical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sofus SølystDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Riina OksjokiDepartment of Cardiology, Copenhagen University Hospital, Herlev-Gentofte and Rigshospitalet, Copenhagen, Denmark.
Stense FarholtDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Dorte Guldbrand NielsenDepartment of Cardiology, Copenhagen University Hospital, Herlev-Gentofte and Rigshospitalet, Copenhagen, Denmark.
Alex H ChristensenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Christina R FagerbergDepartment of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-5206-4327
Lotte RisomDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Pernille Axél GregersenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.ORCID 0000-0003-3424-0590
Maria Bejerholm ChristensenDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5428-0739
Torsten Bloch RasmussenDepartment of Cardiology, Copenhagen University Hospital, Herlev-Gentofte and Rigshospitalet, Copenhagen, Denmark.
Birgitte Rode DinessDepartment of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-9306-3419

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study describes all patients in Denmark with vascular Ehlers-Danlos syndrome (vEDS). Carriers of pathogenic or likely pathogenic COL3A1 variants were retrospectively identified through registries and specialized clinics. Medical records were reviewed for vascular- or organ ruptures and invasive procedures performed. Identified families were divided by variant type (null, splice, and missense) and familial phenotypes (severe or attenuated). Families in which at least one carrier has suffered a major event before the age of 30 were classified as severe, whereas families in which at least three carriers had reached the age of 40 without a major event were classified as attenuated. Eighty-seven persons (59 still alive) from 25 families were included with a mean observation time of 44 years. Sixty-seven percent of patients could be subclassified in a familial phenotype. Thirty-one major events were observed. Eleven complications in 172 invasive procedures were recorded. No fatal complications to elective surgery were observed. The type of COL3A1 variant did not reliably predict phenotype, but a pattern of intrafamilial consistency emerged with some families showing an attenuated form of vEDS. Elective medical procedures appear to be safer than previously thought, although data only allow for conclusions regarding individuals from families with the attenuated form of vEDS.

Indexed as

Collagen Type IIIEhlers-Danlos SyndromeDenmarkElective Surgical ProceduresHumansRetrospective StudiesCOL3A1 protein, humanCollagen Type IIICOL3A1genotype-phenotypesurgical complicationsvascular EDSvascular Ehlers-Danlos syndromevEDS

Identifiers

PMID35699227
PMCPMC9544160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.